Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease
Abstract Current treatment of severe dry eye disease (DED) includes blood-derived eye drops, such as autologous serum (AS), which lubricate the eyes and provide factors that improve ocular surface and aid in wound healing. Recent studies indicated that platelet-rich plasma (PRP) was also effective....
Main Authors: | Chanatip Metheetrairut, Panotsom Ngowyutagon, Abhirak Tunganuntarat, Ladawan Khowawisetsut, Kulvara Kittisares, Pinnita Prabhasawat |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-12879-x |
Similar Items
-
Provocation of dry eye disease symptoms during COVID-19 lockdown
by: Nutnicha Neti, et al.
Published: (2021-12-01) -
The corneal epitheliotrophic abilities of lyophilized powder form human platelet lysates.
by: Lily Wei Chen, et al.
Published: (2018-01-01) -
Autologous Platelet Rich Plasma versus Autologous Serum Eye Drops in Treatment of Severe Dry Eye Disease
by: Esraa Mohammad, et al.
Published: (2022-08-01) -
Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives.
by: Chien-Jung Huang, et al.
Published: (2017-01-01) -
Autologous serum eye drops versus lacrimal gland injection of platelet-rich plasma for severe dry eye
by: Ibrahim Y Allam
Published: (2021-01-01)